Skip to main content
Log in

Therapie des BRAF-V600E-mutierten kolorektalen Karzinoms im metastasierten Stadium

Treatment of metastatic BRAF V600E mutated colorectal carcinoma

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kopetz S, Desai J, Chan E, Hecht JR, O’Dwyer PJ, Maru D, Morris V, Janku F, Dasari A, Chung W et al (2015) Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer. J Clin Oncol 33(34):4032–4038. https://doi.org/10.1200/JCO.2015.63.2497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Corcoran RB, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G et al (2018) Combined BRAF, EGFR, and MEK inhibition in patients with BRAFV600E-mutant colorectal cancer. Cancer Discov 8(4):428–443. https://doi.org/10.1158/2159-8290.CD-17-1226

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R et al (2015) Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600-mutant colorectal cancer. J Clin Oncol 33(34):4023–4031. https://doi.org/10.1200/JCO.2015.63.2471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan Alakus.

Ethics declarations

Interessenkonflikt

A. Pamuk, T. Zander, H. Alakus und C. Bruns geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pamuk, A., Zander, T., Alakus, H. et al. Therapie des BRAF-V600E-mutierten kolorektalen Karzinoms im metastasierten Stadium. Onkologe 26, 292–294 (2020). https://doi.org/10.1007/s00761-019-00703-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-019-00703-7

Navigation